Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (23280)	1/28/1999 1:05:00 PM
From: Jenna	Respond to of 120523

NSOL now trading at 188 5/16 @ 188 5/8.. spread does shrink from time to time. I will close part of the position for profit taking before the day's end. Will someone out there get NSOL to trade options this is ridiculous tying up so much capital.

To: Jenna who wrote (23280)	1/28/1999 1:31:00 PM
From: kha vu	Respond to of 120523

A--....number 2 on watchlist You ask any body know anything about number 2: ..Q4 estimated $0.30 A lot of block trade at 100 k since Jan 20... NDA for neck and head cancer.. here is an excerpt on news release: According to the American Cancer Society, approximately 40,000 cases of head and neck cancer are diagnosed each year in the United States. Radiation therapy, often in conjunction with surgery and/or chemotherapy, is standard treatment for this tumor. ''We believe that Ethyol can make an important contribution to the treatment of many of these patients undergoing radiation therapy,'' said ...... Ethyol is currently indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian or non-small cell lung cancer.